Atropinic (Anticholinergic) Burden in Parkinson's Disease-Reference-Cited by-同舟云学术

Atropinic (Anticholinergic) Burden in Parkinson's Disease

Published:2016-03-29 Issue:5 Volume:31 Page:632-636
ISSN:0885-3185
Container-title:Movement Disorders
language:en
Short-container-title:Mov Disord.

Author:

De Germay Sibylle¹²³,Montastruc Jean-Louis¹²³⁴⁵,Rousseau Vanessa¹²³⁴,Chebane Leila¹²,Bondon-Guitton Emmanuelle¹²³,Moulis Florence¹²,Durrieu Genevieve¹²,Bagheri Haleh¹²³⁵,Rascol Olivier¹⁴⁵⁶,Pariente Antoine⁷⁸,Bégaud Bernard⁷⁸,Montastruc François¹²³⁴⁹

Affiliation:

1. Service de Pharmacologie Médicale et Clinique; Centre Hospitalier Universitaire et Faculté de Médecine de Toulouse; Toulouse France

2. Centre Midi-Pyrénées de PharmacoVigilance, de Pharmacoépidémiologie et d'Informations sur le Médicament et Pharmacopôle Midi-Pyrénées; Centre Hospitalier Universitaire de Toulouse; Toulouse France

3. INSERM UMR 1027, Faculté de Médecine; Université de Toulouse; Toulouse France

4. CIC INSERM 1436; Université et Centre Hospitalier Universitaire de Toulouse; Toulouse France

5. NeuroToul Centre of Excellence in Neurodegeneration; Université et Centre Hospitalier Universitaire; France

6. INSERM UMR 825; Université de Toulouse; Toulouse France

7. Département de Pharmacologie; Université et Centre Hospitalier Universitaire de Bordeaux; Bordeaux France

8. INSERM U 657, Pharmacoepidemiology; Université et Centre Hospitalier Universitaire de Bordeaux; Bordeaux France

9. NeuroToul Centre of Excellence in Neurodegeneration; Université et Centre Hospitalier Universitaire; France. Département de Pharmacologie; Université et Centre Hospitalier Universitaire de Bordeaux; Bordeaux France

Publisher

Wiley

Subject

Clinical Neurology,Neurology

Reference25 articles.

1. Anticholinergics, antimuscarinics or atropinics? About the words in pharmacology;Montastruc;Br J Clin Pharmacol,2010

2. Future directions in the treatment of Parkinson's disease;Schapira;Mov Disord,2007

3. The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the motor symptoms of Parkinson's disease;Fox;Mov Disord,2011

4. The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the non-motor symptoms of Parkinson's disease;Seppi;Mov Disord,2011

5. Anticholinergics for symptomatic management of Parkinson's disease;Katzenschlager;Cochrane Database Syst Rev,2003

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anticholinergic Medication Burden and Cognitive Subtypes in Parkinson's Disease without Dementia;ARCH CLIN NEUROPSYCH;2024

2. The Impact of Polypharmacy on Management of Lower Urinary Tract Symptoms in Parkinson’s Disease;Drugs & Aging;2023-08-31

3. Anticholinergic Burden, Polypharmacy, and Cognition in Parkinson’s Disease Patients with Mild Cognitive Impairment: A Cross-Sectional Observational Study;Dementia and Geriatric Cognitive Disorders;2022

4. Anticholinergic Medication Burden in Parkinson’s Disease Outpatients;Journal of Parkinson's Disease;2021-11-15

5. Poids atropinique et médicaments anticholinergiques : intérêt et application en pratique clinique chez la personne âgée;Therapies;2021-11